EPAM vs KNSA · P/E 14, rev $2.81B vs P/E 53, rev $677.6M
EPAM Systems Inc (EPAM) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the EPAM and KNSA stock pages for the full models.
Not investment advice.